Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sensile Medical Enters into an Agreement with scPharmaceuticals

Published: Wednesday, May 01, 2013
Last Updated: Wednesday, May 01, 2013
Bookmark and Share
The SenseCore technology offers opportunities for improved therapy outcomes and healthcare cost reduction.

Sensile Medical AG has entered into a strategic partnership and supply agreement with scPharmaceuticals LLC to develop and manufacture an automated patch pump that delivers furosemide subcutaneously.

Furosemide is a diuretic that forms the cornerstone of heart failure therapy and is currently used in tablet form or in solution for intravenous administration. scPharmaceuticals has developed a proprietary subcutaneous formulation of furosemide and will use Sensile Medical’s patented SenseCore technology platform to deliver the drug in a patient-friendly and automated way. scPharmaceuticals will start its late-stage clinical development phase in the near future and expects to submit the New Drug Application for the furosemide drug device combination not later than Q1 of 2015.

“We are very pleased to enter this collaboration with scPharmaceuticals” said Derek Brandt, CEO of Sensile Medical. “We believe that our micro pump technology has the potential to address some important therapeutic and economic challenges that the medical community is facing today. “

“The Affordable Care Act has created an urgent need for novel therapies that offer benefits comparable to those achieved by intravenously administered drugs in the hospital, but which can be administered anytime anywhere by the patient”, said Pieter Muntendam, MD, President and CEO of scPharmaceuticals, “The SenseCore Micro-Pump technology stands out because of its precision and the unique and cost-effective two component design.”

Under the terms of the agreement, Sensile Medical will design, develop, and manufacture patch pumps for scPharmaceuticals’ proprietary subcutaneous formulation of furosemide. Furthermore, it establishes a strategic partnership between Sensile Medical and scPharmaceuticals to work together to develop further medications utilizing Sensile’s technology platform. Terms of the agreement were not disclosed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Smart Patch Releases Blood Thinners When Needed
Researchers have developed a smart patch that activelly monitors a patient's blood and releases blood thinning drugs when necessary.
First-Ever Capsule to Treat Hemophilia
In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
New Compound to Reduce Tumor Growth
Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.
Long-Lasting Pill to Fight Malaria
An ultra-long acting pill has been developed to offer a new hope in eliminating malaria.
History of Cells Told Through MEMOIR
MEMOIR technique developed by CalTech researchers enables the life history of cells to be read.
Synthetic Protein Captures DNA Events Leading to Cancer
A team of scientists have developed new technology allowing them to identify molecular intermediates that can drive genetic change.
Precision Medicine for Rheumatoid Arthritis
Researchers identify gene mechanism that increases rheumatoid arthritis risk in susceptable individuals.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!